{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T08:31:36Z","timestamp":1713947496645},"reference-count":4,"publisher":"Japanese Circulation Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2015]]},"DOI":"10.1253\/circj.cj-15-0399","type":"journal-article","created":{"date-parts":[[2015,5,28]],"date-time":"2015-05-28T22:03:21Z","timestamp":1432850601000},"page":"1641","source":"Crossref","is-referenced-by-count":1,"title":["Assessment of the Anticoagulation Activity of Apixaban"],"prefix":"10.1253","volume":"79","author":[{"given":"Luciana Ricca","family":"Gon\u00e7alves","sequence":"first","affiliation":[{"name":"Department of Transfusion Medicine, Centre of Thrombosis and Hemostasis, S\u00e3o Jo\u00e3o University Hospital, Faculty of Medicine, Porto University"}]},{"given":"Fernando","family":"Ara\u00fajo","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine, Centre of Thrombosis and Hemostasis, S\u00e3o Jo\u00e3o University Hospital, Faculty of Medicine, Porto University"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Silvain J, Hauguel M, Kerneis M, Collet JP, Montalescot G; for the ACTION Study Group. Measuring and reversing the effect of non-vitamin K antagonist oral anticoagulants (NOACs) [Editorial]. <i>Circ J<\/i> 2015; 79: 289\u2013291.","DOI":"10.1253\/circj.CJ-14-1382"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Douxfils J, Chatelain C, Chatelain B, Dogn\u00e9 JM, Mullier F. Impact of apixaban on routine and specific coagulation assays: A practical laboratory guide. <i>Thromb Haemost<\/i> 2013; 110: 283\u2013294.","DOI":"10.1160\/TH12-12-0898"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Tobu M, Iqbal O, Hoppensteadt DA, Shultz C, Jeske W, Fareed J. Effects of a synthetic factor Xa inhibitor (JTV-803) on various laboratory tests. <i>Clin Appl Thromb Hemost<\/i> 2002; 8: 325\u2013336.","DOI":"10.1177\/107602960200800404"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Baglin T, Keeling D, Kitchen S. Effects on routine coagulation screens and assessment of anticoagulant intensity in patients taking oral dabigatran or rivaroxaban: Guidance from the British Committee for Standards in Haematology. <i>Br J Haematol<\/i> 2012; 154: 427\u2013429.","DOI":"10.1111\/bjh.12052"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/79\/7\/79_CJ-15-0399\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T12:32:19Z","timestamp":1498221139000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/79\/7\/79_CJ-15-0399\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":4,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-15-0399","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}